Abstract
Alcohol-induced steatohepatitis (ASH) increases the risk for both clinically-severe acute alcoholic hepatitis and eventual cirrhosis. The mechanisms that control ASH pathogenesis and progression are unclear but processes that regulate liver cell plasticity seem to be critically involved. In injured adult livers, morphogenic signaling pathways that modulate cell fate decisions during fetal development and in adult liver progenitors become reactivated. Overly-exuberant activation of such morphogenic signaling causes dysregulated liver repair and increases short- and long-term mortality by promoting acute liver failure, as well as progressive fibrosis. Hence, these pathways may be novel therapeutic targets to optimize liver cell reprogramming and prevent defective regenerative responses that cause acute liver failure and cirrhosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Masarone M, Rosato V, Dallio M, Abenavoli L, Federico A, Loguercio C, Persico M (2016) Epidemiology and natural history of alcoholic liver disease. Rev Recent Clin Trials 11:167–174
Singh S, Murad MH, Chandar AK, Bongiorno CM, Singal AK, Atkinson SR, Thursz MR et al (2015) Comparative effectiveness of pharmacological interventions for severe alcoholic hepatitis: a systematic review and network meta-analysis. Gastroenterology 149:958–970 e912
Jung Y, Witek RP, Syn WK, Choi SS, Omenetti A, Premont R, Guy CD et al (2010) Signals from dying hepatocytes trigger growth of liver progenitors. Gut 59:655–665
Higashi T, Friedman SL, Hoshida Y (2017) Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev 121:27–42
Sicklick JK, Li YX, Choi SS, Qi Y, Chen W, Bustamante M, Huang J et al (2005) Role for hedgehog signaling in hepatic stellate cell activation and viability. Lab Investig 85:1368–1380
Kramann R, Schneider RK, DiRocco DP, Machado F, Fleig S, Bondzie PA, Henderson JM et al (2015) Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell 16:51–66
Kordes C, Sawitza I, Gotze S, Schumacher E, Haussinger D (2015) Beyond fibrosis: stellate cells as liver stem cells. Z Gastroenterol 53:1425–1431
Pires-daSilva A, Sommer RJ (2003) The evolution of signalling pathways in animal development. Nat Rev Genet 4:39–49
Guerrero I, Chiang C (2007) A conserved mechanism of Hedgehog gradient formation by lipid modifications. Trends Cell Biol 17:1–5
Therond PP (2012) Release and transportation of Hedgehog molecules. Curr Opin Cell Biol 24:173–180
Steinhauer J, Treisman JE (2009) Lipid-modified morphogens: functions of fats. Curr Opin Genet Dev 19:308–314
Seijo-Barandiaran I, Guerrero I, Bischoff M (2015) In Vivo imaging of Hedgehog transport in Drosophila Epithelia. Methods Mol Biol 1322:9–18
Powers S, Mu D (2008) Genetic similarities between organogenesis and tumorigenesis of the lung. Cell Cycle 7:200–204
Chari NS, McDonnell TJ (2007) The sonic hedgehog signaling network in development and neoplasia. Adv Anat Pathol 14:344–352
Choi SS, Omenetti A, Witek RP, Moylan CA, Syn WK, Jung Y, Yang L et al (2009) Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. Am J Physiol Gastrointest Liver Physiol 297:G1093–G1106
Yang L, Wang Y, Mao H, Fleig S, Omenetti A, Brown KD, Sicklick JK et al (2008) Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells. J Hepatol 48:98–106
Philips GM, Chan IS, Swiderska M, Schroder VT, Guy C, Karaca GF, Moylan C et al (2011) Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer. PLoS One 6:e23943
Pratap A, Singh S, Mundra V, Yang N, Panakanti R, Eason JD, Mahato RI (2012) Attenuation of early liver fibrosis by pharmacological inhibition of smoothened receptor signaling. J Drug Target 20:770–782
Michelotti GA, Xie G, Swiderska M, Choi SS, Karaca G, Kruger L, Premont R et al (2013) Smoothened is a master regulator of adult liver repair. J Clin Invest 123:2380–2394
Hirsova P, Ibrahim SH, Bronk SF, Yagita H, Gores GJ (2013) Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis. PLoS One 8:e70599
Ochoa B, Syn WK, Delgado I, Karaca GF, Jung Y, Wang J, Zubiaga AM et al (2010) Hedgehog signaling is critical for normal liver regeneration after partial hepatectomy in mice. Hepatology 51:1712–1723
Swiderska-Syn M, Syn WK, Xie G, Kruger L, Machado MV, Karaca G, Michelotti GA et al (2014) Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy. Gut 63:1333–1344
Swiderska-Syn M, Xie G, Michelotti GA, Jewell ML, Premont RT, Syn WK, Diehl AM (2016) Hedgehog regulates yes-associated protein 1 in regenerating mouse liver. Hepatology 64:232–244
Yimlamai D, Christodoulou C, Galli GG, Yanger K, Pepe-Mooney B, Gurung B, Shrestha K et al (2014) Hippo pathway activity influences liver cell fate. Cell 157:1324–1338
Su T, Bondar T, Zhou X, Zhang C, He H, Medzhitov R (2015) Two-signal requirement for growth-promoting function of Yap in hepatocytes. Elife 4
Fitamant J, Kottakis F, Benhamouche S, Tian HS, Chuvin N, Parachoniak CA, Nagle JM et al (2015) YAP inhibition restores Hepatocyte differentiation in advanced HCC, Leading to tumor regression. Cell Rep
Lee DH, Park JO, Kim TS, Kim SK, Kim TH, Kim MC, Park GS et al (2016) LATS-YAP/TAZ controls lineage specification by regulating TGFbeta signaling and Hnf4alpha expression during liver development. Nat Commun 7:11961
Yi J, Lu L, Yanger K, Wang W, Sohn BH, Stanger BZ, Zhang M et al (2016) Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ. Hepatology 64:1757–1772
Jung Y, Brown KD, Witek RP, Omenetti A, Yang L, Vandongen M, Milton RJ et al (2008) Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. Gastroenterology 134:1532–1543
Syn WK, Jung Y, Omenetti A, Abdelmalek M, Guy CD, Yang L, Wang J et al (2009) Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. Gastroenterology 137:1478–1488 e1478
Sancho-Bru P, Altamirano J, Rodrigo-Torres D, Coll M, Millan C, Jose Lozano J, Miquel R et al (2012) Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis. Hepatology 55:1931–1941
Affo S, Dominguez M, Lozano JJ, Sancho-Bru P, Rodrigo-Torres D, Morales-Ibanez O, Moreno M et al (2013) Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis. Gut 62:452–460
Karaca G, Swiderska-Syn M, Xie G, Syn WK, Kruger L, Machado MV, Garman K et al (2014) TWEAK/Fn14 signaling is required for liver regeneration after partial hepatectomy in mice. PLoS One 9:e83987
Dubuquoy L, Louvet A, Lassailly G, Truant S, Boleslawski E, Artru F, Maggiotto F et al (2015) Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis. Gut 64:1949–1960
Kharkar PS (2017) Cancer Stem Cell (CSC) inhibitors: a review of recent patents (2012–2015). Expert Opin Ther Pat 27:753–761
Shukla G, Khera HK, Srivastava AK, Khare P, Patidar R, Saxena R (2017) Therapeutic potential, challenges and future perspective of Cancer stem cells in translational oncology: a critical review. Curr Stem Cell Res Ther 12:207–224
Cheng E, Armstrong CL, Galisteo R, Winkles JA (2013) TWEAK/Fn14 Axis-targeted therapeutics: moving basic science discoveries to the clinic. Front Immunol 4:473
McDonald OG, Wu H, Timp W, Doi A, Feinberg AP (2011) Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nat Struct Mol Biol 18:867–874
Kidder BL, Hu G, Yu ZX, Liu C, Zhao K (2013) Extended self-renewal and accelerated reprogramming in the absence of Kdm5b. Mol Cell Biol 33:4793–4810
Sahu M, Mallick B (2016) An integrative approach predicted co-expression sub-networks regulating properties of stem cells and differentiation. Comput Biol Chem 64:250–262
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this paper
Cite this paper
Diehl, A.M. (2018). Developmental Morphogens & Recovery from Alcoholic Liver Disease. In: Vasiliou, V., Zakhari, S., Mishra, L., Seitz, H. (eds) Alcohol and Cancer. Advances in Experimental Medicine and Biology, vol 1032. Springer, Cham. https://doi.org/10.1007/978-3-319-98788-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-98788-0_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98787-3
Online ISBN: 978-3-319-98788-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)